Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)

SHA:688062 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,120	1,193	1,651	2,491	96.54	305.17
Short-Term Investments	-	35.87	35.26	-	-	-
Trading Asset Securities	10	3.77	14.88	60.12	-	242.74
Cash & Short-Term Investments	1,130	1,232	1,701	2,551	96.54	547.92
Cash Growth	-37.17%	-27.56%	-33.32%	2542.47%	-82.38%	1241.79%
Accounts Receivable	40.83	38.34	17.51	0.07	0.14	0.23
Other Receivables	119.49	100.05	112.27	82.65	33.01	51.7
Receivables	160.32	138.39	129.78	82.73	33.15	51.92
Inventory	220.22	211.68	159.3	79.05	40.11	34.79
Other Current Assets	148.16	122.84	57.48	65.12	74.93	32.55
Total Current Assets	1,658	1,705	2,048	2,778	244.74	667.18
Property, Plant & Equipment	2,020	2,053	1,935	1,263	811.64	517.34
Long-Term Investments	57.8	46.66	41.95	20.2	18.95	-
Goodwill	118.77	118.77	118.77	118.77	118.77	118.77
Other Intangible Assets	150.88	152.81	139.72	161.31	179.4	191.5
Long-Term Deferred Charges	6.07	6.39	0.98	6.13	12.71	19.49
Other Long-Term Assets	179.17	192.76	170.98	271.93	209.07	124.61
Total Assets	4,191	4,276	4,455	4,619	1,595	1,639
Accounts Payable	116.8	100.23	62.32	45.21	39.69	22.56
Accrued Expenses	84.84	153.03	138.12	82.25	57.53	26.07
Short-Term Debt	1,073	921.6	209.27	100.14	10.82	50.04
Current Portion of Long-Term Debt	210.55	113.65	1.59	0.6	0.15	-
Current Portion of Leases	-	31.52	26.96	21.02	18.83	-
Current Income Taxes Payable	33.71	-	3.34	-	-	-
Current Unearned Revenue	42.84	36.01	13.52	36.65	63.53	6.2
Other Current Liabilities	194.59	185.67	361.26	159.27	79.85	61.97
Total Current Liabilities	1,756	1,542	816.39	445.14	270.41	166.84
Long-Term Debt	962.27	1,006	887.72	492.12	132.05	-
Long-Term Leases	131.73	142.97	167.11	160.57	172.72	-
Long-Term Unearned Revenue	24.85	27.07	10.59	11.03	11.47	1.61
Other Long-Term Liabilities	52.77	1.53	-	-	-	-
Total Liabilities	2,928	2,720	1,882	1,109	586.65	168.45
Common Stock	399.6	399.6	399.6	399.6	299.7	299.7
Additional Paid-In Capital	5,960	5,959	5,931	5,812	2,456	2,146
Retained Earnings	-5,087	-4,795	-3,751	-2,698	-1,743	-973.1
Comprehensive Income & Other	5.04	5.08	4.8	1.56	-2.6	-1.75
Total Common Equity	1,277	1,569	2,584	3,516	1,011	1,471
Minority Interest	-13.83	-13.1	-10.45	-5.08	-2.18	-0.21
Shareholders' Equity	1,263	1,556	2,573	3,511	1,009	1,470
Total Liabilities & Equity	4,191	4,276	4,455	4,619	1,595	1,639
Total Debt	2,378	2,216	1,293	774.45	334.58	50.04
Net Cash (Debt)	-1,248	-983.91	408.4	1,777	-238.03	497.88
Net Cash Growth	-	-	-77.01%	-	-	1119.24%
Net Cash Per Share	-3.13	-2.46	1.02	4.54	-0.79	1.75
Filing Date Shares Outstanding	399.6	399.6	399.6	399.6	299.7	299.7
Total Common Shares Outstanding	399.6	399.6	399.6	399.6	299.7	299.7
Working Capital	-97.96	163.47	1,231	2,333	-25.68	500.34
Book Value Per Share	3.20	3.93	6.47	8.80	3.37	4.91
Tangible Book Value	1,008	1,297	2,325	3,236	712.64	1,160
Tangible Book Value Per Share	2.52	3.25	5.82	8.10	2.38	3.87
Buildings	-	753.02	181.83	3.06	3.06	3.06
Machinery	-	1,206	653.69	440.39	420.08	394.01
Construction In Progress	-	240.87	1,131	804.49	313.24	192.2

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.